This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
XARELTO® (rivaroxaban)
Medical Information
XARELTO - Reversal agents in human studies - Other - Activated charcoal
Last updated : 08/25/2025
Specific response
Menu
In a case report documented by Mehta et al (2012)1:
- A 21-month-old female ingested two 10 mg tablets of XARELTO.
- Activated charcoal (1 g/kg) was given approximately 2 hours after ingestion.
- The patient’s INR peaked to 3.5 approximately 12 hours after ingestion, and subsequently fell to 1.7 at 20 hours after ingestion of the tablets.
INR, international normalized ratio.
Reference
Show Hide
1. Mehta PD, Christian MR, Kanter MZ. Coagulopathy after accidental pediatric rivaroxaban ingestion. Clin Toxicol. 2012;50(7):Abstract 3
Connect with us
Connect with us
Live video
Waiting for agent...
A Medical Information Specialist will assist you shortly. When your Specialist has joined, a button to join the video call will appear here.
Ready to join
Click or tap the button below to join the video call with your Medical Information Specialist:
Would you like to clear and leave your conversation? Message history will be lost.